Physician profile
Edward Tackey
NPI 1669488110
$3,454.13
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,404 · 2020: $30.00 · 2022: $20.08.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 108 LLC | $3,125.20 | 2019 | |
| Amgen INC. | $130.90 | 2019-2022 | |
| Ucb, INC. | $71.42 | 2019-2020 | |
| Pfizer INC. | $59.09 | 2019 | |
| Janssen Biotech, INC. | $36.18 | 2019 | |
| Genzyme Corporation | $18.07 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.27 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Tackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.